HomeOwner SearchCategory Search
Novel Insights into TLR4:TLR3 Crosstalk in Response to TLR4 Specific Ultrapure Lipopolysaccharide (LPS) from Highly Pathogenic<em> Escherichia coli</em> 0111:B4 in Murine Microglia
Visit USCO
hero image
Text Registration
Copyright Title

Novel Insights into TLR4:TLR3 Crosstalk in Response to TLR4 Specific Ultrapure Lipopolysaccharide (LPS) from Highly Pathogenic<em> Escherichia coli</em> 0111:B4 in Murine Microglia

Status

Published

on 31 May 2021
Year of Creation
2021
Copyright Claimant
Brett Arthur LaBier
Registration Number
TX0008986660
on 31 May 2021

Copyright Summary


The U.S. Copyright record (Registration Number: TX0008986660) dated 31 May 2021, pertains to an electronic file (eService) titled "Novel Insights into TLR4:TLR3 Crosstalk in Response to TLR4 Specific Ultrapure Lipopolysaccharide (LPS) from Highly Pathogenic<em> Escherichia coli</em> 0111:B4 in Murine Microglia" created in 2021. The copyright holder is Brett Arthur LaBier, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Brett Arthur LaBier.

Copyright Details


Copyright Claimant
Brett Arthur LaBier

Application Details


Registration Number
TX0008986660
Registration Date
5/31/2021
Year of Creation
2021
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States

Personal Authors


Notes


Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements


Application Title Statement: Novel Insights into TLR4:TLR3 Crosstalk in Response to TLR4 Specific Ultrapure Lipopolysaccharide (LPS) from Highly Pathogenic<em> Escherichia coli</em> 0111:B4 in Murine Microglia
Author Statement: Brett Arthur LaBier Citizenship: not known Authorship: text
Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

© 2024 reserved by Trademarkia
Show terms & conditions